(Total Views: 1091)
Posted On: 01/27/2021 11:59:27 AM
Post# of 153903
I emailed Janet Woodcock last Friday -
I didn't know how much Janet knew about leronlimab and the pivotal Phase 2b/3 clinical trial. So I wrote to her that the data from the trial will be submitted to the FDA very soon if it hasn't been done already.
I mentioned Fauci and that he is well aware of leronlimab and its function as a CCR5 inhibitor.
Janet wrote back, "WE all look forward to the trial results. Janet W"
I didn't know how much Janet knew about leronlimab and the pivotal Phase 2b/3 clinical trial. So I wrote to her that the data from the trial will be submitted to the FDA very soon if it hasn't been done already.
I mentioned Fauci and that he is well aware of leronlimab and its function as a CCR5 inhibitor.
Janet wrote back, "WE all look forward to the trial results. Janet W"
(23)
(0)
